• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Repigmentation and new growth of hairs after anti-interleukin-17 therapy with secukinumab for psoriasis.

作者信息

Rongioletti Franco, Mugheddu Cristina, Murgia Severino

机构信息

Unit of Dermatology, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.

出版信息

JAAD Case Rep. 2018 May 7;4(5):486-488. doi: 10.1016/j.jdcr.2018.01.006. eCollection 2018 Jun.

DOI:10.1016/j.jdcr.2018.01.006
PMID:29984292
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6031562/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8296/6031562/870c0dfc663e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8296/6031562/870c0dfc663e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8296/6031562/870c0dfc663e/gr1.jpg

相似文献

1
Repigmentation and new growth of hairs after anti-interleukin-17 therapy with secukinumab for psoriasis.使用司库奇尤单抗进行抗白细胞介素-17治疗后银屑病的色素再生和毛发新生。
JAAD Case Rep. 2018 May 7;4(5):486-488. doi: 10.1016/j.jdcr.2018.01.006. eCollection 2018 Jun.
2
Secukinumab for patients failing previous tumour necrosis factor-α inhibitor therapy: results of a randomized open-label study (SIGNATURE).司库奇尤单抗用于既往肿瘤坏死因子-α抑制剂治疗失败的患者：一项随机开放标签研究（SIGNATURE）的结果
Br J Dermatol. 2020 Jul;183(1):60-70. doi: 10.1111/bjd.18623. Epub 2019 Dec 25.
3
The effect of secukinumab treatment for psoriasis on serum cytokines and correlation with disease severity.司库奇尤单抗治疗银屑病对血清细胞因子的影响及其与疾病严重程度的相关性。
Skin Res Technol. 2023 Jul;29(7):e13405. doi: 10.1111/srt.13405.
4
Guselkumab versus secukinumab for the treatment of moderate-to-severe psoriasis (ECLIPSE): results from a phase 3, randomised controlled trial.古塞库单抗与司库奇尤单抗治疗中重度银屑病（ECLIPSE）：一项 3 期随机对照临床试验的结果。
Lancet. 2019 Sep 7;394(10201):831-839. doi: 10.1016/S0140-6736(19)31773-8. Epub 2019 Aug 8.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病：网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗：一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
8
Efficacy of Risankizumab versus Secukinumab in Patients with Moderate-to-Severe Psoriasis: Subgroup Analysis from the IMMerge Study.司库奇尤单抗与瑞莎珠单抗治疗中重度银屑病患者的疗效对比：IMMerge研究的亚组分析
Dermatol Ther (Heidelb). 2022 Feb;12(2):561-575. doi: 10.1007/s13555-021-00679-6. Epub 2022 Jan 20.
9
Efficacy, safety, and drug survival of IL-23, IL-17, and TNF-alpha inhibitors for psoriasis treatment: a retrospective study.IL-23、IL-17 和 TNF-α 抑制剂治疗银屑病的疗效、安全性和药物生存情况：一项回顾性研究。
J Dermatolog Treat. 2022 Jun;33(4):2352-2357. doi: 10.1080/09546634.2021.1961998. Epub 2021 Aug 13.
10
Effects of secukinumab combined with tretinoin on metabolism, liver enzymes, and inflammatory factors in patients with moderate to severe psoriasis vulgaris.司库奇尤单抗联合维甲酸对中度至重度寻常型银屑病患者代谢、肝酶及炎症因子的影响。
Postepy Dermatol Alergol. 2024 Feb;41(1):113-120. doi: 10.5114/ada.2023.135605. Epub 2024 Feb 28.

引用本文的文献

1
Premature hair graying: a multifaceted phenomenon.早发性白发：一种多方面的现象。
Int J Dermatol. 2025 May;64(5):819-829. doi: 10.1111/ijd.17580. Epub 2024 Dec 19.
2
Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress.逆转白发：通过毛发色素形成和再着色进展的研究为新疗法的开发带来启示。
Int J Biol Sci. 2023 Aug 28;19(14):4588-4607. doi: 10.7150/ijbs.86911. eCollection 2023.
3
Cerebrolysin induces hair repigmentation associated to MART-1/Melan-A reactivation.

本文引用的文献

1
Pigmentary changes in patients treated with targeted anticancer agents: A systematic review and meta-analysis.接受靶向抗癌药物治疗患者的色素沉着变化：一项系统评价和荟萃分析。
J Am Acad Dermatol. 2017 Nov;77(5):902-910.e2. doi: 10.1016/j.jaad.2017.06.044. Epub 2017 Sep 14.
2
Hair Repigmentation During Immunotherapy Treatment With an Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 Agent for Lung Cancer.使用抗程序性细胞死亡蛋白1和抗程序性细胞死亡配体1药物治疗肺癌期间的毛发再色素沉着
JAMA Dermatol. 2017 Nov 1;153(11):1162-1165. doi: 10.1001/jamadermatol.2017.2106.
3
Drug-induced hair colour changes.
脑活素诱导毛发复色与 MART-1/Melan-A 再激活相关。
Eur J Med Res. 2022 Nov 21;27(1):257. doi: 10.1186/s40001-022-00889-4.
4
Updates on the Treatment of Erythrodermic Psoriasis.红皮病型银屑病治疗的最新进展
Psoriasis (Auckl). 2021 Jun 9;11:59-73. doi: 10.2147/PTT.S288345. eCollection 2021.
5
Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo.进展期及白发型白癜风患者循环中白细胞介素-17A水平升高。
Dermatol Res Pract. 2021 Apr 21;2021:5524566. doi: 10.1155/2021/5524566. eCollection 2021.
6
Hair whitening in a patient with psoriasis on adalimumab reversed after switching to ixekizumab.一名使用阿达木单抗治疗的银屑病患者出现头发变白，改用司库奇尤单抗后头发变白情况逆转。
JAAD Case Rep. 2021 Mar 16;11:51-53. doi: 10.1016/j.jdcr.2021.03.008. eCollection 2021 May.
7
Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis.2例银屑病患者使用白细胞介素17阻滞剂后出现全身性多毛症。
JAAD Case Rep. 2020 May 23;6(7):683-685. doi: 10.1016/j.jdcr.2020.05.023. eCollection 2020 Jul.
Eur J Dermatol. 2016 Dec 1;26(6):531-536. doi: 10.1684/ejd.2016.2844.
4
Repigmentation of hair following adalimumab therapy.阿达木单抗治疗后毛发再色素沉着。
Dermatol Online J. 2015 Jun 16;21(6):13030/qt6fn0t1xz.
5
Rationale for the development of speckled hyperpigmentation in the areas of psoriatic plaques after treatment with biologic agents.生物制剂治疗后银屑病斑块部位出现斑点状色素沉着的发生机制。
J Invest Dermatol. 2015 Jan;135(1):318-320. doi: 10.1038/jid.2014.297. Epub 2014 Jul 18.
6
IL-17 and TNF synergistically modulate cytokine expression while suppressing melanogenesis: potential relevance to psoriasis.白细胞介素-17 和肿瘤坏死因子协同调节细胞因子表达，同时抑制黑色素生成：与银屑病的潜在相关性。
J Invest Dermatol. 2013 Dec;133(12):2741-2752. doi: 10.1038/jid.2013.237. Epub 2013 Apr 30.
7
IL-4 inhibits the melanogenesis of normal human melanocytes through the JAK2-STAT6 signaling pathway.IL-4 通过 JAK2-STAT6 信号通路抑制正常人黑素细胞的黑素生成。
J Invest Dermatol. 2013 Feb;133(2):528-36. doi: 10.1038/jid.2012.331. Epub 2012 Sep 20.
8
Dysregulation of melanocyte function by Th17-related cytokines: significance of Th17 cell infiltration in autoimmune vitiligo vulgaris.Th17 相关细胞因子对黑素细胞功能的失调作用：Th17 细胞浸润在自身免疫性寻常型白癜风中的意义。
Pigment Cell Melanoma Res. 2012 Mar;25(2):219-30. doi: 10.1111/j.1755-148X.2011.00945.x. Epub 2012 Feb 10.
9
RXRα ablation in epidermal keratinocytes enhances UVR-induced DNA damage, apoptosis, and proliferation of keratinocytes and melanocytes.表皮角质细胞中 RXRα 的缺失增强了 UVR 诱导的角质细胞和黑素细胞的 DNA 损伤、凋亡和增殖。
J Invest Dermatol. 2011 Jan;131(1):177-87. doi: 10.1038/jid.2010.290. Epub 2010 Oct 14.
10
Imatinib mesylate and gray hair.甲磺酸伊马替尼与白发
N Engl J Med. 2002 Aug 8;347(6):446. doi: 10.1056/NEJM200208083470614.